Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Triamcinolone 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing precisely fludrocortisone acetate 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Flunisolide 25 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing prednicarbate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Prednicarbate 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing clocortolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
clocortolonpivalat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing precisely clocortolone pivalate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
mometasonfuroatmonohydrat 0,05 % vandig næsespray uden duftstof |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 64 µg vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 200 µg tørpulver cylinderampul og genopfyldeligt inhalationsudstyr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
clobetasonbutyrat + oxytetracyclin + nystatin creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing fluprednidene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing fluprednidene and miconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Fluprednidene acetate 1 mg/g and miconazole nitrate 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing budesonide and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 80 µg + formoterol 4,5 µg tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 160 µg + formoterol 4,5 µg tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 320 µg + formoterol 9 µg tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Amcinonide 1 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Fluocinolone acetonide 100 microgram/mL cutaneous oil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Dermasmoothe/fs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 200 µg inhalator med spacer-anordning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 400 µg inhalationspulver kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 200 µg inhalationspulver kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
diflorasondiacetat 0,5 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
triamcinolonacetonid 0,055 mg/inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 8.4mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
loteprednoletabonat + tobramycin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
methylprednisolonacetat 80 mg/ml injektionsvæske, suspension, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing precisely fluocinonide 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
budesonid 200 µg tørpulver cylinderampul til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing ciclesonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
ciclesonid 80 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
ciclesonid 160 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
mometasonfuroat 200 µg hættaktiveret tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
fluocinolon 0,59 mg implantat til anvendelse i øje |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Prednisolone 3 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
salmeterol 25 µg + fluticasonpropionat 50 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
salmeterol 25 µg + fluticasonpropionat 125 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
salmeterol 50 µg + fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
salmeterol 50 µg + fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
salmeterol 50 µg + fluticasonpropionat 0500 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
Product containing fluticasone and salmeterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|